In Mexico, there is no specific body of legislation governing data protection exclusivity (DPE), also known as regulatory exclusivity, for chemical drugs, biological medical products and new indications. 627 more words
Tags » Michael Best
Mr. Luiz Otávio Pimentel has been appointed as the new president of INPI (the Brazilian Patent and Trademark Office – BRPTO). The official notice for the nomination was published yesterday, July 28, 2015, in the Federal Register. 284 more words
New Patent Examination Guidance In Canada For Evaluating Medical Diagnostic Methods: Will Canada's Application Be More Flexible Than The U.S.?
Patentable Subject Matter in Canada
In Canada, patentable subject matter is embodied in section 2 of the Canadian Patent Act (Patent Act), which defines an invention as “any new and useful art, process, machine, manufacture or composition of matter, or any new and useful improvement in any art, process, machine, manufacture or composition of matter”. 1,456 more words
Did you miss the BRIC panel “Strategies for Successfully Mastering the Different Challenges of the IP Systems in the BRIC Countries and U.S. in the Pharmaceutical and Life Sciences Sectors,” presented in conjunction with the 2015 BIO International Convention? 16 more words
This is Part 6 of an 8-part series examining post-grant review proceedings, oppositions, and third party observations in the U.S., BRIC and several non-BRIC countries. To see Part 1, Post-Grant Oppositions in Japan, click… 879 more words